Kurth, K H <br/><br/>
Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.  [electronic resource] 

 -  Progress in clinical and biological research  1988 
 - 525-37 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0361-7742 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intravesical<br/>Carcinoma, Transitional Cell--drug therapy<br/>Clinical Trials as Topic<br/>Combined Modality Therapy<br/>Doxorubicin--administration & dosage<br/>Follow-Up Studies<br/>Humans<br/>Mitomycin<br/>Mitomycins--administration & dosage<br/>Neoplasm Recurrence, Local--prevention & control<br/>Random Allocation<br/>Time Factors<br/>Urinary Bladder Neoplasms--drug therapy